Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DGLA cream in infants with moderate to severe atopic dermatitis
2015-002838-46Phase 2Terminated
- Sponsor
- DS Biopharma
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in atopic dermatitis (AD) comparing Hydrocortisone butyrate + DGLA, then DGLA alone with Hydrocortisone butyrate + vehicle, then vehicle alone (2 arms). Primary endpoint: Change in Investigators Global Assessment from baseline to Day 63. Started Jul 2015; status: terminated.
02
Drugs
docosahexaenoic acid + gamma-linolenic acid
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2015-002838-46.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002838-46.